Patents Assigned to Edison Parmaceuticals, Inc. a Delaware Corporation
  • HYDROGENATED PYRIDO[4,3-b]INDOLES FOR THE TREATMENT OF OXIDATIVE STRESS
    Publication number: 20100029706
    Abstract: Methods of treating or suppressing oxidative stress diseases including mitochondrial diseases, impaired energy processing disorders, and diseases of aging such as diabetes and cancer with hydrogenated pyrido[4,3-b]indoles such as dimebolin, are disclosed.
    Type: Application
    Filed: July 29, 2009
    Publication date: February 4, 2010
    Applicant: Edison Parmaceuticals, Inc. a Delaware Corporation
    Inventors: Guy M. Miller, Kieron E. Wesson